00:00
←not started
ready
cycle —
2:00
auto-resumes after shock ·
immediate post-ROSC full note ↗
12-lead ECG → STEMI/cath · SpO₂ 92–98% · ETCO₂ 35–45 · MAP ≥65 · avoid fever
ended · ·
work in progress —
hands-off 0:00
CCF —
shocks 0
drugs
events
H&Ts
log
doses
ACLS
Epinephrine
1 mg IV/IO q3–5 min · non-shockable: ASAP · shockable: after initial shocks fail1
Amiodarone
300 mg bolus → 150 mg · shock-refractory VF/pVT1
Lidocaine
1–1.5 mg/kg → 0.5–0.75 mg/kg · alternative to amiodarone1
Shock
biphasic: device default (120–200 J), unknown → max · monophasic 360 J · VF/pVT1
Refractory VF
vector change (AP pads) or dual sequential defibrillation — usefulness not established · shock-refractory VF1
special circumstances
Alteplase (PE)
50 mg IV/IO bolus over 2 min → repeat 50 mg if no ROSC at 15 min (UpToDate) / 30 min (ERC) · suspected PE · start anticoagulation · CPR ≥60–90 min after lysis4,3,2
Calcium chloride 10% (↑K)
10 mL rapid IV; repeat if refractory · hyperkalaemic arrest3
Calcium gluconate 10%
⅓ the Ca²⁺ per mL of chloride: 30 mL ≈ CaCl 10% 10 mL · alternative to CaCl2,3
Sodium bicarbonate (↑K)
50 mmol IV (separate line/flush from Ca) · hyperkalaemic arrest3
Insulin + dextrose (↑K)
10 U regular IV + 25 g dextrose (D50 50 mL; 50 g = 100 mL) · hyperkalaemic arrest2
Magnesium sulfate
2 g (8 mmol) IV over 1–2 min · torsades3
Naloxone
0.2–2 mg IV/IO/IM · opioid2
Lipid emulsion 20%
>70 kg: 100 mL over 2–3 min → 200–250 mL over 15–20 min · <70 kg: 1.5 mL/kg · local anaesthetic toxicity2
Sodium bicarbonate (tox)
50–150 mmol IV · Na-channel blocker (e.g. TCA)2
Calcium chloride 10% (tox)
20 mL IV (central preferred) · CCB / β-blocker2
Hypothermia <30 °C
one shock then defer; defer epinephrine until ≥30 °C · hypothermic arrest2
- Wigginton JG, et al. Part 9: Adult Advanced Life Support. 2025 AHA Guidelines for CPR and ECC. Circulation. 2025;152(suppl 2):S538–S577.
- Part 10: Adult and Pediatric Special Circumstances of Resuscitation. 2025 AHA Guidelines for CPR and ECC. Circulation. 2025;152(suppl 2):S578–S672.
- Lott C, Karageorgos V, et al. European Resuscitation Council Guidelines 2025: Special Circumstances in Resuscitation. Resuscitation. 2025;215:110753.
- UpToDate. Alteplase: Drug information — Dosing: pulmonary embolism, associated with cardiac arrest (off-label). Accessed 2026-11-12.